Issue 4

More than 80 stakeholders from around the world recently finished development of the first-ever classification criteria for IgG4-related disease from ACR and the European League Against Rheumatism (EULAR).

On Saturday, the ACR Board of Directors met to discuss current and future initiatives, as well as challenges and opportunities that impact the ACR’s 9,500 members. ACR President David I. Daikh, MD, who completes his term at this Annual Meeting, led the meeting. Paula Marchetta,…

During the annual Business Meeting on Tuesday, the ACR will install the 82nd president of the American College of Rheumatology, Paula Marchetta, MD, MBA.

Researchers have worked to revise the classification criteria for giant cell arteritis and Takayasu’s arteritis, which were adopted in 1990.

When it comes to effectively treating patients with arthritis, rheumatologist and sports medicine specialist Andrew Concoff, MD, says exercise is the key.

With more than half the states currently allowing the use of medical marijuana, rheumatologists increasingly see patients who have questions about whether marijuana might help in the management of their rheumatic diseases.

The Centers for Medicare and Medicaid Services now include emergency response and preparedness as an approved quality improvement area for consideration in alternative payment models, making this a good time for clinics to take stock.

The Rheumatology Research Foundation recognized 153 award recipients at the Awards Celebration, an annual luncheon, held Monday.

Even with limited time to spend away from your practice, you can have an impact on issues important to rheumatology! Here are a few helpful resources to do just that.

Recognizing the need to improve care for patients with rheumatic diseases during their reproductive years, ACR has developed a new clinical guideline.